Stay updated on Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.

Latest updates to the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page
- Check4 days agoChange DetectedNew results posting details were added to the page (Results First Submitted 2025-02-28 and Results First Posted 2025-04-13) along with updated Study Record Dates, introducing outcome reporting information to the page.SummaryDifference0.2%

- Check11 days agoChange DetectedCali, Colombia (760035) was added as a study location, and Santiago de Cali, Colombia (760035) was removed. This updates the list of sites where the trial is conducted and where participants can enroll.SummaryDifference0.1%

- Check32 days agoChange DetectedAdded a government funding notice and an updated software version (v3.2.0), removing the old v3.1.0; this primarily updates the page’s operating status guidance and versioning.SummaryDifference1%

- Check40 days agoChange DetectedThe page now announces Revision: v3.1.0 and removes four drug-safety related topics, indicating content reorganization and scope narrowing.SummaryDifference0.1%

- Check54 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; removed the 'Back to Top' link; no other substantive core content changes detected.SummaryDifference0.1%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

Stay in the know with updates to Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.